ArticleBMC cancer2021

Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.

Ying Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.